Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bodybuilding Health+ vs yourEra

Bodybuilding Health+
Site position #33

Lower grade

yourEra
Site position #8

Higher grade

The verdict

yourEra takes it — 83.8/100 to 78.1/100.

yourEra grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBodybuilding Health+ +6
88
82
Dose & formulationBodybuilding Health+ +2
84
82
Clinical oversightyourEra +11
74
85
Labs & monitoringyourEra +17
68
85
FulfillmentyourEra +8
78
86
Contract termsyourEra +23
62
85
Bodybuilding Health+ · top baryourEra · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBodybuilding Health+yourEra
WeighScore78.1/10083.8/100
GradeC+B
Site position#33#8
Semaglutide$179/mo month-to-month (3/6/12-month prepay: $159.33/$158/$141.50 per month)$199/mo
Tirzepatide$209/mo month-to-month (3/6/12-month prepay: $179/$174.67/$187.33 per month — the 12-month rung is badged Best Value and costs more than the 6-month one)$299/mo
CoverageNot disclosedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Bodybuilding Health+

Site position #33 · C+

Strengths

  • Both price ladders are published before intake: semaglutide $179/month or $141.50 per month on a 12-month prepay; tirzepatide $209/month with lower monthly equivalents on prepaid plans
  • Licensed brand extension of Bodybuilding.com (trademark relationship stated on-site), which lends familiarity vs. anonymous GLP-1 startups
  • Unusually broad menu under one login — GLP-1 plus NAD+ (injection or nasal), sermorelin (injection or sublingual ODT), ED/tadalafil, and a deep peptide catalog
  • Standard telehealth flow with clear FDA/compounding disclaimers — online intake reviewed by independent licensed providers, U.S. compounding-pharmacy fulfillment, free until a provider approves

Where it loses points

  • The 12-month tirzepatide plan is labeled Best Value at $187.33 per month, but the six-month plan costs $174.67 per month. Both require prepayment; the longer commitment does not deliver the lowest monthly equivalent
  • Compounded and not FDA-approved — not Wegovy/Ozempic or Zepbound/Mounjaro; the site itself states these have not been evaluated by the FDA for safety, effectiveness, or quality
  • Brand-new operator — Dynamo Group LLC launched the storefront around April 2026 with only a thin, mixed ~26-review Trustpilot record (cancellation and billing complaints)
  • All sales final — prescription products are non-returnable, the medical-consult fee is non-refundable, and there are no refunds for dissatisfaction or results
  • Pharmacy and provider network aren't named on the live consumer pages, no LegitScript seal we could verify on-site, and the catalog reaches into investigational Retatrutide and research-grade peptides
yourEra

Site position #8 · B

Strengths

  • Transparent, publicly listed pricing — many compounded competitors hide price behind a quiz
  • Both semaglutide and tirzepatide, not a single-drug menu, plus NAD+ and microdosing lines
  • Markets a 50-state licensed-clinician network; no insurance required, HSA/FSA accepted
  • Optional yourEra Optimum membership adds 1:1 coaching, a nutritionist, at-home lab draws and wearables

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Mid-market pricing ($199 sema / $299 tirz) — above the cheapest compounders
  • No brand-name lane and no oral route — weekly injectable only
  • Thin independent footprint; the 50-state and efficacy claims are self-reported

Featured provider

yourEra

yourEra scores 83.8/100 (B). A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard